Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:16:52.776Z.
Calculation as of: 2026-10-06T16:16:52.776Z.
Quote observation: 2026-10-06T16:10:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fe223a2c9097866a428bc5ebda2476775355ce68fd4daeb413d6e89482dd9b46
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
GlucoTrack, Inc.
Market Cap
$869976.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$859931.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$858810.00
Operating Cash Flow Yield
N/A
TTM Avg
0.01%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$845829.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$816286.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$809925.00
Operating Cash Flow Yield
N/A
TTM Avg
431.27%
3Y Avg
544.33%
5Y Avg
879.33%
Market Cap
$1.04M
Operating Cash Flow Yield
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.06M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$669300.00
Operating Cash Flow Yield
18593.46%
TTM Avg
1695.05%
3Y Avg
1337.72%
5Y Avg
1337.72%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GlucoTrack, Inc. (GCTK) | $869976.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | N/A | 0.01% | 0.01% | 0.01% |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $816286.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | 431.27% | 544.33% | 879.33% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A | 0.00% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $669300.00 | 18593.46% | 1695.05% | 1337.72% | 1337.72% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
